期刊文献+

131’I治疗Graves’病临床效果及其影响因素的研究 被引量:4

The research of clinical therapeutic effect in 131^I treatment of Graves' disease and affecting factors
原文传递
导出
摘要 目的评价Graves’病131^I治疗1年后的临床效果,探讨影响其疗效的因素。方法182例131^I治疗患者疗效按成功治愈(正常+甲减)、治疗失败(仍为甲亢+复发)分组,比较两组的性别、年龄、甲状腺重量、摄碘率、FT3、FT4、给定的131^I即131^I治疗系数、131^I剂量、单位质量甲状腺组织131^I剂量。Logistic回归分析甲状腺重量、单位质量甲状腺组织131^I剂量、FT4、131^I治疗系数4个因素与成功治愈概率的关系。结果131^I治疗1年后共随访到114例,仍为甲亢者32例(28%),恢复正常者41例(36%),转为甲减者37例(32.5%),复发者4例(3.5%)。成功治愈率为68.4%,失败率为31.6%。成功治愈组治疗前的甲状腺大小、FT4水平低于治疗失败组,131^I治疗系数、单位质量甲状腺组织131^I剂量明显高于治疗失败组。Logistic回归分析中,单位质量甲状腺组织131^I剂量对成功治愈有统计学意义(P=0.049)。结论Graves’病患者治疗前甲状腺重量、FT4水平、131^I治疗系数、单位质量甲状腺组织131^I剂量是影响131^I治疗效果的因素,并为评估预后的指标;单位质量甲状腺组织131^I剂量与成功治愈独立正相关。 Objective To evaluate the clinical therapeutic effect in 131^I treatment of Gravess' disease, explore its affecting factors. MethodsThe therapeutic effects was divided into successful cure( euthy- roidism or hypothyroidism)and unsuccessful cure (persistent or recurrent hyperthyroidism). Gender,age, thyroid weight,131^I uptake,FT3 ,FT4 ,given 131^I called 131^I treatment coefficient and dose 131^I to thyroid/g tissue were compared in the two groups. The correlation was analysed between the four factors: thyroid weight ,dose 131^I to thyroid/g tissue,FT4 131^I treatment coefficient and successful cure in Logistic Regression. Results After one year 114 subjects had been successfully followed up,32 patients (28%)had persistent hyperthyroidism ,41 ( 36% ) ,37 ( 32.5% ) ,4( 3.5% ) were euthyroid 、hypothyroid,recurrent hyper-thyroidism respectively. The percentage of successful cure is 68.4% ,unsuccessful cure 31.6%. The thy-roid size and level of serum FT4 before treatment in the successful cure group were lower than the unsuc-cessful group;131^I treatment coefficient and dose 131^I to thyroid/g tissue were obviously higher. Logistic Regression analysis displayed dose 131^I to thyroid/g tissue had a significant impact in successful cure. Conclusion The thyroid weight 、serum FT4 ,131^I treatment coefficient、dose 131^I to thyroid/g tissue can become the indicators of prognosis. Dose 131^I to thyroid/g tissue is independently and positively with success-ful cure.
出处 《临床内科杂志》 CAS 2011年第9期597-600,共4页 Journal of Clinical Internal Medicine
关键词 Graves’病 131^I治疗 Graves' disease 131^I treatment
  • 相关文献

参考文献13

  • 1Abraham P,Acharya S.Current and emerging treatment options for Graves' hyperthyroidism.Ther Clin Risk Manag,2010,6:29-40. 被引量:1
  • 2张春凯,肖全章,蔡福祥,阎桂珍,赵景波,卢明俊,赵宝贵.Graves病流行病学研究[J].中国公共卫生,1995,11(12):531-533. 被引量:9
  • 3Hollowell JG,Staehling NW,Flanders WD,et al.Serum TSH,T4,and thyroid antibodies in the United States population(1988-1994):National Health and Nutrition Examination Survey (NHANES Ⅲ).J Clin Endocrinol Metab,2002,87:489-499. 被引量:1
  • 4Cooper DS.Hyperthyroidism.Lencet,2003,362:459-468. 被引量:1
  • 5Vaidya B,Williams GR,Abraham P,et al.Radioiodine treatment for benign thyroid disorders:results of a nationwide survey of UK endocrinologists.Clin Endocrinol(Oxf),2008,68:814-820. 被引量:1
  • 6Alexander EK,Larsen PR.High dose of 131I therapy for the treatment of hyperthyroidism caused by Graves' disease.J Clin Endocrinol Metab,2002,87:1073-1077. 被引量:1
  • 7Weetman AP.Radioiodine treatment for benign thyroid diseases.Clin Endocrinol(Oxf),2007,66:757-764. 被引量:1
  • 8Metso S,Jaatinen P,Huhtala H,et al.Long-tern follow-up study of radioiodine treatment of hyperthyroidism.Clin Endocrinol (Oxf),2004,61:641-648. 被引量:1
  • 9Hern(a)ndez-Jim(e)nez S,Pach(o)n-Burgos A,Aguilar-Salinas CA,et al.Radiotodine treatment in autoinunum:hyperthyroidism:analysis of outcomes in relation to dosage.Arch Med Res,2007,38:185-189. 被引量:1
  • 10邢家骝.131I治疗良性甲状腺功能亢进症.见:邢家骝.主编.131碘治疗甲状腺疾病.第1版.北京:人民卫生出版社,2002.152-196. 被引量:1

共引文献8

同被引文献31

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部